Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma

The emerging targeted therapies have revolutionized the treatment of advanced clear cell renal cell carcinoma (ccRCC) over the past 15 years. Nevertheless, lack of personalized treatment limits the development of effective clinical guidelines and improvement of patient prognosis. In this study, larg...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhicheng, Lin, Dongxu, Zhou, Yi, Zhang, Linmeng, Yang, Chen, Guo, Bin, Xia, Feng, Li, Yan, Chen, Danyang, Wang, Cun, Chen, Zhong, Leng, Chao, Xiao, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345903/
https://www.ncbi.nlm.nih.gov/pubmed/35918352
http://dx.doi.org/10.1038/s41598-022-16657-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345903/
https://www.ncbi.nlm.nih.gov/pubmed/35918352
http://dx.doi.org/10.1038/s41598-022-16657-7

Ejemplares similares